# US 6,726,924 B2 · Oral liposomal delivery system

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,726,924 B2
- Document ID: US6726924B2
- Status: Granted
- Kind: B2
- Application number: 09/148,499
- Filed: 1998-09-04
- Published: 2002-04-04
- Granted: 2004-04-27
- Earliest claimed: 1997-09-04
- Assignees: BioZone Laboratories, Inc.
- Inventors: Brian C. Keller
- Web page: https://patentgrep.com/patent/US6726924B2

## CPC

- A61K 9/4858: {Organic compounds}
- A61K 9/127: Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A liposome-capsule dosage unit system for the delivery of a biologically active material is formed by encapsulating a biologically active materials in liposomes and then placing the liposome encapsulated material into a capsule. The capsule is typically a soft gel capsule or a two piece capsule capable of tolerating a certain amount of water. A less water tolerant capsule can be employed if the liposomes are dehydrated prior to placement within the capsule. Biologically active material include drugs, nutritional supplements, vitamins, minerals, enzymes, hormones, proteins and polypeptides. The system is especially suited for the delivery of materials with poor oral solubility, materials that are not absorbed or are poorly absorbed from the gastrointestinal tract, and materials that have conventionally been given by an invasive route. The system can be administered orally, intra-occularly, intranasally, rectally, or vaginally.

## Claims

### Claim 1

A method for preparing a liposome formulation in a gelatin capsule, comprising:
formulating a liposome dispersion, wherein said liposome dispersion is formulated by mixing a lipid component, an active ingredient component, a water component, and an oil component such that said dispersion comprises liposomes in a fluid medium, wherein said fluid medium comprises said water and said oil components; and
directly inserting the liposome dispersion into the capsule.

### Claim 2 (depends on 1)

The method of claim 1, wherein the lipid is selected from the group consisting of phospholipids, sphingolipids, glycosphingolipids, and ceramides.

### Claim 3 (depends on 1)

The method of claim 1, wherein the capsule is a soft gel capsule.

### Claim 4 (depends on 1)

The method of claim 1, wherein the capsule is composed of two pieces.

### Claim 5 (depends on 1)

The method of claim 1, wherein the biologically active material is selected from the group consisting of drugs, nutritional supplements, vitamins, minerals, enzymes, hormones, proteins, and peptides.

### Claim 6 (depends on 1)

A liposome formulation in a capsule prepared by the process of claim 1.

### Claim 7 (depends on 1)

The method of claim 1, wherein the oil component comprises Vitamin E.

### Claim 8 (depends on 1)

The method of claim 1, wherein said fluid medium comprises a low aqueous system.

### Claim 9 (depends on 1)

The method of claim 1, wherein said water component comprises no greater than about 10% of the total fluid medium.

### Claim 10 (depends on 1)

The method of claim 1, wherein said water component comprises about 4% to 10% of the total fluid medium.

### Claim 11 (depends on 1)

The method of claim 1, wherein said water concentration within the total fluid medium does not exceed the water tolerance of the gelatin capsule.

### Claim 12 (depends on 6)

The capsule of claim 6, wherein the lipid is selected from the group consisting of phospholipids, sphingolipids, glycosphingolipids, and ceramides.

### Claim 13 (depends on 6)

The capsule of claim 6, wherein the active material selected from the group consisting of drugs, nutritional supplements, vitamins, minerals, enzymes, hormones, proteins, and peptides.

### Claim 14 (depends on 6)

The capsule of claim 6, wherein the capsule is a soft gel capsule.

### Claim 15 (depends on 6)

The capsule of claim 6, wherein the capsule is composed of two pieces.

### Claim 16

A capsule for delivering an active ingredient to a subject comprising a liposome dispersion, wherein said liposome dispersion comprises a lipid component, an active ingredient component, a water component, and an oil component such that said dispersion comprises liposomes in a fluid medium, wherein said fluid medium comprises said water and said oil components.

### Claim 17 (depends on 16)

The capsule of claim 16, wherein the oil component comprises Vitamin E.

### Claim 18 (depends on 16)

The capsule of claim 16, wherein said fluid medium comprises a low aqueous system.

### Claim 19 (depends on 16)

The capsule of claim 16, wherein said water component comprises a concentration no greater than about 10% of the total fluid medium.

### Claim 20 (depends on 16)

The capsule of claim 16, wherein said water component comprises about 4% to 10% of the total fluid medium.

### Claim 21 (depends on 16)

The capsule of claim 16, wherein said water concentration within the total fluid medium does not exceed the water tolerance of the gelatin capsule.

### Claim 22 (depends on 16)

The method of claim 16, wherein the lipid is selected from the group consisting of phospholipids, sphingolipids, glycosphingolipids, and ceramides.

### Claim 23 (depends on 16)

The method of claim 16, wherein the active material selected from the group consisting of drugs, nutritional supplements, vitamins, minerals, enzymes, hormones, proteins, and peptides.

### Claim 24 (depends on 16)

The method of claim 16, wherein the capsule is a soft gel capsule.

### Claim 25 (depends on 16)

The method of claim 16, wherein the capsule is composed of two pieces.

### Claim 26

A method for administering a biologically active material to a subject, which method comprises introducing a capsule to the subject by oral administration, wherein:
the capsule comprises a liposome dispersion; and
the liposome dispersion comprises a lipid component, an active ingredient component, a water component, and an oil component such that said dispersion comprises liposomes in a fluid medium, wherein said fluid medium comprises said water and said oil components.

### Claim 27 (depends on 26)

The method of claim 26, wherein the oil component comprises Vitamin E.

### Claim 28 (depends on 26)

The method of claim 26, wherein said fluid medium comprises a low aqueous system.

### Claim 29 (depends on 26)

The method of claim 26, wherein said water component comprises no greater than about 10% of the total fluid medium.

### Claim 30 (depends on 26)

The method of claim 26, wherein said water component comprises about 4% to 10% of the total fluid medium.

### Claim 31 (depends on 26)

The method of claim 26, wherein said water concentration within the total fluid medium does not exceed the water tolerance of the gelatin capsule.
